Your session is about to expire
← Back to Search
Adults with Advanced Lung Cancer for Lung Cancer
N/A
Waitlist Available
Led By Katherine Ramos, Ph.D.
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks, 1 month follow-up (up to 4 months)
Awards & highlights
Study Summary
The purpose of this study to use Self-system therapy (SST), to treat depression and lung-cancer-related distress in older adults (65 years and older).
Eligible Conditions
- Lung Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 12 weeks, 1 month follow-up (up to 4 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks, 1 month follow-up (up to 4 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Patients That Complete SST Treatment Sessions
Patient Satisfaction With Treatment
Secondary outcome measures
Depression as Measured by the Beck Depression Inventory (BDI-II) at 1-month Follow-up
Depression as Measured by the Beck Depression Inventory (BDI-II) at 12 Weeks
Depression as Measured by the Beck Depression Inventory (BDI-II) at Baseline
+9 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Adults with Advanced Lung CancerExperimental Treatment1 Intervention
Older adults with stage III or stage IV lung cancer will be enrolled in the Self-System Therapy intervention to treat illness-related distress, depression, and to enhance self-efficacy via delivery of behavioral coping skills across a period of 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Self-System Therapy for Older Adults with Advanced Lung Cancer (SST-LC)
2020
N/A
~30
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,716 Previous Clinical Trials
7,510,993 Total Patients Enrolled
Duke UniversityLead Sponsor
2,377 Previous Clinical Trials
3,427,136 Total Patients Enrolled
Katherine Ramos, Ph.D.Principal InvestigatorDuke University
3 Previous Clinical Trials
122 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger